Suppr超能文献

微波消融与射频消融治疗肝包膜下肝癌:一项倾向评分匹配研究。

Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.

Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jing 5 Rd, Jinan, 250021, Shandong, China.

出版信息

Eur Radiol. 2022 Jul;32(7):4657-4666. doi: 10.1007/s00330-022-08537-5. Epub 2022 Jan 29.

Abstract

OBJECTIVES

Thermal ablation is now accepted as one of the curative treatments for patients with early-stage hepatocellular carcinoma (HCC), but the efficacy of this treatment for subcapsular HCC is not well characterized. Therefore, we aimed to compare the outcomes of microwave ablation (MWA) and radiofrequency ablation (RFA) for patients with subcapsular HCC.

METHODS

In total, 195 patients with subcapsular HCC who met the Milan criteria and underwent MWA or RFA were included. Local tumor progression (LTP), overall survival (OS), recurrence beyond the Milan criteria (RBM), and complications of these patients were compared.

RESULTS

After propensity score matching, the 1-, 3-, and 5-year cumulative LTP rates were 6.7%, 9.6%, and 11.4% in the MWA group, and 13.4%, 24.6%, and 29.1% in the RFA group, respectively (p = 0.006). The cumulative rates of RBM were lower in patients treated with MWA than in those treated with RFA (4.4% versus 12% at 1 year; 14.5% versus 23.0% at 3 years; and 37.4% versus 53.9% at 5 years; p = 0.03). The OS rates at 1, 3, and 5 years were 97.1%, 85.9%, and 73.4% in the MWA group, and 95.6%, 80.4%, and 61.4% in the RFA group, respectively (p = 0.36). The rate of major complications showed no significant difference between the MWA group and the RFA group (17.4% vs. 11.6%, p = 0.33).

CONCLUSION

Compared to RFA, MWA showed better tumor control for subcapsular HCC within the Milan criteria. There was no difference in the incidence of major complications between the two groups.

KEY POINTS

•Compared to radiofrequency ablation, microwave ablation showed better local tumor control for patients with subcapsular hepatocellular carcinoma. •Microwave ablation showed similar major complication rates for patients with subcapsular hepatocellular carcinoma. •Microwave ablation may be preferred for patients with subcapsular hepatocellular carcinoma when they need to receive thermal ablation.

摘要

目的

热消融术现已被接受为治疗早期肝细胞癌(HCC)患者的一种有治愈可能的治疗方法,但该治疗方法对包膜下 HCC 的疗效尚不清楚。因此,我们旨在比较微波消融(MWA)和射频消融(RFA)治疗包膜下 HCC 患者的疗效。

方法

共纳入 195 例符合米兰标准并接受 MWA 或 RFA 治疗的包膜下 HCC 患者。比较了这些患者的局部肿瘤进展(LTP)、总生存期(OS)、超出米兰标准的复发(RBM)以及并发症。

结果

经过倾向评分匹配后,MWA 组 1、3 和 5 年累积 LTP 率分别为 6.7%、9.6%和 11.4%,RFA 组分别为 13.4%、24.6%和 29.1%(p=0.006)。MWA 组患者的 RBM 累积发生率低于 RFA 组(1 年时分别为 4.4%和 12%;3 年时分别为 14.5%和 23.0%;5 年时分别为 37.4%和 53.9%;p=0.03)。MWA 组患者的 1、3 和 5 年 OS 率分别为 97.1%、85.9%和 73.4%,RFA 组分别为 95.6%、80.4%和 61.4%(p=0.36)。MWA 组和 RFA 组的主要并发症发生率无显著差异(17.4%与 11.6%,p=0.33)。

结论

与 RFA 相比,MWA 对包膜下 HCC 患者在米兰标准内显示出更好的肿瘤控制效果。两组的主要并发症发生率无差异。

关键点

  • 与射频消融相比,微波消融可为包膜下肝细胞癌患者提供更好的局部肿瘤控制效果。

  • 微波消融为包膜下肝细胞癌患者提供了相似的主要并发症发生率。

  • 当包膜下肝细胞癌患者需要接受热消融治疗时,可能更倾向于使用微波消融。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验